Joslin Diabetes Center is excited to launch a new initiative aimed at exploring new ways to implement diabetes prevention on a national scale through education, treatment and affiliation networks. This will be an ongoing effort focused on:
- catalyzing prevention activities;
- engaging academic, patient advocacy, public and private sector resources; and
- addressing cost-effective efforts to bring diabetes prevention to scale.
On July 12, 2011, Joslin convened a group of researchers, clinicians, advocates, and policymakers in Washington, D.C. to discuss how to effectively translate the best and most current evidence on diabetes prevention into practice. The discussion centered around the landmark Diabetes Prevention Program (DPP) and subsequent studies that tested various translation projects in the community. The group then discussed what would be required to operationalize the findings.
The Diabetes Prevention Summit: Translating Clinical Science into Practice
A by-invitation-only consensus summit co-sponsored by Joslin Diabetes Center and Health Affairs.
July 12, 2011
John L. Brooks III, President and CEO, Joslin Diabetes Center
Sachin Jain, MD, Physician, Brigham and Women's Hospital and Former Senior Advisor to the Administrator, Center for Medicare and Medicaid Services
Susan Dentzer, Editor-in-Chief, Health Affairs
Bringing Diabetes Prevention To National Scale--blog post on Health Affairs website
“The Diabetes Prevention Summit meeting convened by Joslin Diabetes Center and Health Affairs brought together leaders in the diabetes community – clinicians, researchers, patient advocates, and payers. The Innovation Center received valuable input regarding potential innovative care delivery and payment models for diabetes patients and providers that can reduce costs while improving quality.”
— Richard Gilfillan, MD. Acting Director, Center for Medicare and Medicaid Innovation
"Diabetes is one of the most serious health challenges in America today. But research shows it is largely preventable, presenting partners across the health system with a tremendous opportunity and responsibility to advance real change.
In order to tackle the epidemic head on, it is critical that proven, science-based prevention measures are made accessible and affordable to the people who are most vulnerable to the disease, particularly those enrolled in Medicare and Medicaid. The Diabetes Prevention Program is a powerful answer, and UnitedHealth Group – working with the CDC and the Y – is bringing it to people in private health plans; but we are committed and have the resources to help extend it to those with Medicare and Medicaid. By convening some of the best minds in diabetes prevention and research today, the Joslin Diabetes Center and Health Affairs helped deliver a reminder of the urgency need to give Medicaid and Medicare populations the tools and a roadmap to take greater control over their health and work toward living diabetes-free. The meeting marked a great step forward in our common goal to tip the scales against this epidemic.”
— Deneen Vojta, MD. Executive Vice President and Chief Medical Officer, UnitedHealth Group Diabetes Prevention and Control Alliance; Senior Vice President, UnitedHealth Center for Health Reform & Modernization
Background Publications on Diabetes Prevention
- Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin.
Diabetes Prevention Program Research Group. N Engl J Med 2002; 346:393-403.
- Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study.
Lindström et al., on behalf of the Finnish Diabetes Prevention Study Group. Lancet 2006; 368: 1673–79.
- Translating the Diabetes Prevention Program into the Community: The DEPLOY Pilot Study.
Ackermann et al. Am J Prev Med 2008; 35(4): 357–363.
- 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study.
Diabetes Prevention Program Research Group. Lancet 2009; 374: 1677–86.
- Long-term Effects of a Lifestyle Intervention on Weight and Cardiovascular Risk Factors in Individuals With Type 2 Diabetes Mellitus: Four-Year Results of the Look AHEAD Trial.
The Look AHEAD Research Group. Arch Intern Med 2010; 170(17): 1566-1575.
- One-Year Results of a Community-Based Translation of the Diabetes Prevention Program: Healthy-Living Partnerships to Prevent Diabetes (HELP PD) Project. Katula et al. Diabetes Care 2011; 34: 1451–1457.
Page last updated: December 15, 2018